Lipoprotein(a) in Coronary Disease: An Emerging Novel Target (Steven E Nissen, MD) February 14, 2019
LIVESTREAM RECORDING February 14, 2019 Lipoprotein(a) in Coronary Disease: An Emerging Novel Target” Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference featuring Steven E. Nissen, MD as he discusses “Lipoprotein(a) in Coronary Disease: An Emerging Novel Target". Introductions: William Zoghbi, MD Speaker: Steven E. Nissen, MD, MACC _______________________________________________________________ HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER GRAND ROUNDS STATEMENT OF NEED This program is designed, in light of reviewing quality data retrieved from weekly evaluations, to provide physicians, faculty, fellows and residents access to topics in current basic and clinical research to improve patient care. TARGET AUDIENCE The target audience for this activity is: Cardiology and Cardiovascular Surgery Physicians, Fellows, Residents, NPs, PAs, Nurses, Radiologic Technologists, Sonographers and Research Coordinators. EDUCATIONAL OBJECTIVES At the conclusion of this activity, the participant should be able to: • Discuss updates on diagnosis, treatment and management of cardiovascular disease. • Integrate data and available technique in order to reach appropriate treatment decisions. • Describe research models, methods and statistical tools.

PVCs: The Good, The Bad and The Ugly (Fermin C. Garcia, MD) February 7, 2019

Dyslipidemia Management in 2026 – Updated Guidelines (Drs. Patel, Al-Kindi, Avenatti, and Nasir)

Advances in Lipoprotein (a) | Cardiology Grand Rounds

Michael E. DeBakey - My Memories of a Legend (Kenneth L. Mattox, MD) December 17, 2020

Atrial Fibrillation (AFIB) Review Recent AFIB Research and Your Questions (Dr. Wolf)

Latest Lipoprotein(a) Update: What it Means for You and Your Heart

High Lp(a)? Here's What Works (And What Doesn't)

Lp(a): Assessing and Treating a Major Source of Atherosclerosis - CME Recording

Lp(a) Explained: Genetics, Risk, and What You Can Actually Do

Elevated Lipoprotein “little a”. What's the best treatment for Lp(a)?

Lipoprotein(a): Who's Most at Risk

3.30.23 Grand Rounds Conference

New Drugs Cut Lp(a) Over 90%...Will They Prevent Heart Attacks?

Dr. Paul Mason - 'The truth about high cholesterol'

AFIB Questions with Sandy Schrameyer (Dr. Randall Wolf)

The Role of Lp(a) in Cardiology: Clinic, Echo and Cath Labs

Lipoprotein(a): An ASCVD Risk Factor That Can No Longer Be Ignored

3.09.23 Grand Rounds: Treatment of Lipids in 2023: Where are we now and where are we going?: Trea...

What is LP(a)? Does It Cause Heart Disease? #heartdisease #statins

